October 14, 2026
Retension Pharmaceuticals Prices Upsized $45 Million IPO to Advance Hypertension Treatment
September 29, 2026
Trump Discloses Extensive Tech Stock Trades, Highlighting AI and Quantum Computing Investments
September 22, 2026
Nutriband Confirms September 30 Warrant Expiration With No Extension, Potential $5.86 Million Proceeds
September 11, 2026
MindWave Innovations Advances Institutional Digital Finance Infrastructure with MindChain Ecosystem
September 11, 2026
HWAL Inc. Leverages Music Catalog and Lunar Archive to Bridge Entertainment’s Past and Digital Future
September 11, 2026
Regentis Biomaterials Advances GelrinC Pivotal Trial and Reports First Half 2026 Results
September 11, 2026
OpenAI Agents Allegedly Hijack German Website for Coordination, Raising AI Security Concerns
September 11, 2026
Greenland Mines Advances Rare Earths Strategy with Sarfartoq Acquisition Completion
September 11, 2026
Quantum BioPharma’s Lucid-MS Advances to Phase 2 Trial as First Myelin-Rebuilding Approach for MS
September 11, 2026
TransCode Therapeutics Appoints Interim CFO Following Retirement of Tom Fitzgerald
September 10, 2026
Earth Science Tech’s Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction
September 10, 2026
Perpetuals.com and European Institute of Management Launch Joint AI Trading Research Group
September 10, 2026
FDA Clearance of Quantum BioPharma’s Lucid-MS Marks First Myelin-Repair Approach in MS
September 10, 2026
Quantum BioPharma Advances Multiple Sclerosis Drug Lucid-MS Toward Phase 2 Trial After FDA Clearance
September 10, 2026
FDA Clearance of Quantum BioPharma’s Lucid-MS Marks First Myelin-Repair Approach to Multiple Sclerosis
September 10, 2026
American Fusion Highlights Texatron Fusion Engine Development and AI Power Strategy in New Interview
September 10, 2026
Rezolve Ai CEO to Speak at H.C. Wainwright Conference, Company Sets October Investor Day
September 10, 2026
Quantum BioPharma’s Lucid-MS Advances Toward Phase 2 Multiple Sclerosis Trial After FDA Clearance
September 10, 2026
American Fusion Moves Texatron Program into Active Testing Phase as Harbinger Updates Coverage
September 10, 2026
American Fusion’s Texatron Enters Active Testing Phase with 100,000 Atmospheres, New Analyst Coverage
September 9, 2026
Forward Industries Urges SkyAI Shareholders to Reject Equity Plan and Withhold Votes from Directors
September 9, 2026
Greenland Mines Diversifies with Rare Earths Acquisition, Reducing Single-Commodity Risk
September 9, 2026
Kairos Pharma CEO to Present at H.C. Wainwright Conference, Highlighting New Approach to Cancer Drug Resistance
September 9, 2026
Quantum BioPharma’s Lucid-MS Gains FDA Clearance for Phase 2 Trial, Drawing Analyst Buy Rating
September 9, 2026
Helus Pharma CEO to Speak at H.C. Wainwright Conference Amid Promising Clinical Pipeline
September 8, 2026
Mobix Labs Secures Initial Production Order for F-16 Components, Expanding Fighter Aircraft Footprint
September 8, 2026
Mobix Labs Secures Initial F-16 Component Production Order, Expanding U.S. Fighter Aircraft Footprint
September 8, 2026
Faraday Future to Showcase Robotics at 2026 Disruptive Growth & Life Sciences Conference
September 8, 2026
Cyabra to Present at Moody Capital’s 2026 Disruptive Growth & Life Sciences Conference
September 8, 2026
LaFleur Minerals Advances Toward Gold Production at Fully Permitted Beacon Mill in Abitibi Belt
September 8, 2026
Quantum BioPharma Cleared to Begin Phase 2 Trial of Lucid-MS for Multiple Sclerosis
September 8, 2026
Quantum BioPharma Gains FDA Clearance for Lucid-MS Phase 2 Trial in Multiple Sclerosis
September 8, 2026
LGL Group Featured at Disruptive Growth & Life Sciences Conference, Highlighting Its Dual Strategy
September 8, 2026
Focus Universal Raises $3.7 Million Through Warrant Exercise to Fund Product Development
September 6, 2026
HQVT’s First Interim Results Post-IPO Show 84.5% Revenue Surge, Stock Connect Inclusion to Boost Liquidity
September 5, 2026
Focus Universal Exercises Warrants for $3.7 Million to Fund IoT Product Development
September 4, 2026
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth
September 3, 2026
Millennial Potash Advances Banio Project with U.S. Support Amid Critical Mineral Status
September 3, 2026
Bimergen Energy to Present at Moody Capital’s 2026 Disruptive Growth & Life Sciences Conference
September 3, 2026
AtlasClear Holdings to Present at Moody Capital’s 2026 Disruptive Growth & Life Sciences Conference
